tiprankstipranks
COMPASS Pathways (MX:CMPSN)
:CMPSN
Mexico Market
CMPSN
COMPASS Pathways
RESEARCH TOOLSreports

COMPASS Pathways (CMPSN) Stock News & Sentiment

0 Followers
COMPASS Pathways: Strong Phase 3 TRD Data, Differentiated Positioning Support Unchanged $24 Price Target and Buy Rating
Premium
Ratings
COMPASS Pathways: Strong Phase 3 TRD Data, Differentiated Positioning Support Unchanged $24 Price Target and Buy Rating
6d ago
CMPS
Compass Pathways Advances Redefine PTSD Trial, Keeping Psychedelic Therapy Hopes Alive
Premium
Company Announcements
Compass Pathways Advances Redefine PTSD Trial, Keeping Psychedelic Therapy Hopes Alive
11d ago
CMPS
Compass Pathways (CMPS) Earnings Call Highlights COMP360’s Path
Premium
Company Announcements
Compass Pathways (CMPS) Earnings Call Highlights COMP360’s Path
26d ago
CMPS
Ritu Baral Reiterates Buy on COMPASS Pathways as COMP360 Advances Toward 2027 Launch with Strong Cash Runway
Premium
Ratings
Ritu Baral Reiterates Buy on COMPASS Pathways as COMP360 Advances Toward 2027 Launch with Strong Cash Runway
1M ago
CMPS
Wells Fargo, BKR, SLB, HAL, CMPS Trending With Analysts
Premium
Weekend Updates
Wells Fargo, BKR, SLB, HAL, CMPS Trending With Analysts
2M ago
BKR
HAL
Analyst Reaffirms Buy on CMPS, Viewing Post-Data Pullback as Entry Opportunity Ahead of 1H27 Launch
Premium
Ratings
Analyst Reaffirms Buy on CMPS, Viewing Post-Data Pullback as Entry Opportunity Ahead of 1H27 Launch
2M ago
CMPS
Compass Pathways reports positive Phase 3 depression results
Premium
Company Announcements
Compass Pathways reports positive Phase 3 depression results
2M ago
8K
CMPS
More MX:CMPSN News >

CMPSN News on the Web

Psychedelic: Optimi to initiate Phase 2 trial of psilocybin-assisted therapy
TipRanks News
Bullish
COMPASS Pathways: Strong Phase 3 TRD Data, Differentiated Positioning Support Unchanged $24 Price Target and Buy Rating
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: SOPHiA GENETICS (SOPH) and COMPASS Pathways (CMPS)
TipRanks News
Neutral
COMPASS Pathways (CMPS) Q2 2026 Earnings Call Transcript
The Motley Fool
Neutral
Analysts’ Top Healthcare Picks: COMPASS Pathways (CMPS), Trulieve Cannabis (TRLV)
TipRanks News
Bullish
Compass Pathways initiated with an Equal Weight at Wells Fargo
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
MX:CMPSN
Sector Average
Media Buzz
This Week7 articles
Weekly Average2 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

FAQ

What is MX:CMPSN’s Media Buzz Sentiment?
7 articles about MX:CMPSN were published this week. In an average week, 2 articles are published.
    What is MX:CMPSN’s weekly average amount of articles?
    In an average week, 2 articles about MX:CMPSN are published.
      What is MX:CMPSN’s News Sentiment?
      100% of articles about MX:CMPSN were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        BAYRYBayer
        MRKMerck & Company
        TMDXTransMedics Group
        FSPKFFisher & Paykel Healthcare Corporation Limited
        KURAKura Oncology
        Showing the stocks with the most bullish news sentiment over the past week